MedTrace Logo

Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors

NCT02600156 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2025-12-17

No results posted yet for this study

Summary

The primary purpose of this study is to evaluate the feasibility and safety of MRI-guided focal laser ablation (Laser-Induced Interstitial Thermal Therapy, LITT) to treat low-risk native prostate cancer.

Conditions

  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Stage I Prostate Cancer AJCC v8
  • Stage II Prostate Cancer AJCC v8
  • Localized Prostate Carcinoma

Interventions

PROCEDURE

Focal laser ablation of the prostate

MR guided laser ablation of the focal prostatic lesion which has been identified by MRI and biopsy prior to ablation.

Sponsors & Collaborators

Principal Investigators

  • David Woodrum, MD, PhD · Mayo Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-01
Primary Completion
2025-08-20
Completion
2025-12-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02600156 on ClinicalTrials.gov